Global Calcium Pvt. Limited is pleased to announce the successful completion of a Good Manufacturing Practices (GMP) inspection conducted by ANVISA (Agência Nacional de Vigilância Sanitária), Brazil's National Health Surveillance Agency, from August 17 to 21, 2026.

The inspection covered the company's manufacturing facilities at SIPCOT Industrial Complex, Hosur, Tamil Nadu, along with the associated Central Material Warehouse, and was conducted under RDC 654/2022 – API GMP, in line with the PIC/S GMP Guide for Medicinal Products – Part II.

During the closing meeting, ANVISA inspectors acknowledged that the facilities are well maintained, the Quality System is robust, and the teams are highly knowledgeable and efficient. The site was confirmed to be in a state of full GMP compliance, marking the fourth regulatory inspection in under two years to conclude in complete conformance.

In line with ANVISA's standard post-inspection process, the agency will formally issue the inspection report and the Certificate of GMP Compliance (CBPF).

Global Calcium remains committed to maintaining the highest standards of quality and regulatory compliance across all its facilities.